Biosimilar adalimumab: Phase I data

A 3-arm, Dutch Phase I trial in healthy volunteers showed that ONS-3010 met the primary pharmacokinetic endpoints of bioequivalence to both the U.S.- and EU-sourced Humira adalimumab reference produc...